Analyst Ratings For ADMA Biologics Inc (NASDAQ:ADMA)
Today, Maxim Group reiterated its Buy rating on ADMA Biologics Inc (NASDAQ:ADMA) with a price target of $12.00.
There are 6 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on ADMA Biologics Inc (NASDAQ:ADMA) is Buy with a consensus target price of $10.1667 per share, a potential 133.72% upside.
Some recent analyst ratings include
- 8/27/2019-ADMA Biologics Inc (NASDAQ:ADMA) had its Buy rating reiterated by Maxim Group with a $12.00 price target
- 8/12/2019-ADMA Biologics Inc (NASDAQ:ADMA) gets downgraded to Neutral by Dawson James with a price target of $4.00
- 6/4/2019-ADMA Biologics Inc (NASDAQ:ADMA) has coverage initiated with a Buy ➝ Buy rating and $8.00 price target
- 10/12/2018-ADMA Biologics Inc (NASDAQ:ADMA) had its Buy rating reiterated by Raymond James with a $10.00 price target
- On 6/6/2019 Biotest Divestiture Trust, Major Shareholder, sold 5,813,954 with an average share price of $3.75 per share and the total transaction amounting to $21,802,327.50.
- On 5/21/2019 Life Sciences Maste Perceptive, Major Shareholder, bought 4,000,000 with an average share price of $4.00 per share and the total transaction amounting to $16,000,000.00.
- On 5/17/2019 Adam S Grossman, Insider, bought 30,000 with an average share price of $4.00 per share and the total transaction amounting to $120,000.00.
- On 5/17/2019 Brian Lenz, CFO, bought 5,000 with an average share price of $4.00 per share and the total transaction amounting to $20,000.00.
- On 5/17/2019 James Mond, EVP, bought 4,500 with an average share price of $4.00 per share and the total transaction amounting to $18,000.00.
- On 5/17/2019 Lawrence P Guiheen, Director, bought 25,000 with an average share price of $4.00 per share and the total transaction amounting to $100,000.00.
- On 6/8/2018 Adam S Grossman, CEO, bought 52,301 with an average share price of $4.78 per share and the total transaction amounting to $249,998.78.
Recent Trading Activity for ADMA Biologics Inc (NASDAQ:ADMA)
Shares of ADMA Biologics Inc closed the previous trading session at 4.35 up +0.31 7.67% with 4.05 shares trading hands.